Slide 1: SGX General Announcement: Results Briefing FY2019
General Announcement::Results Briefing FY2019 Page 1 of 2 GENERAL ANNOUNCEMENT::RESULTS BRIEFING FY2019 Issuer & Securities Issuer/ Manager HYPHENS PHARMA INTERNATIONAL LIMITED Securities HYPHENS PHARMA INTL LIMITED - SG1EE4000006 - 1J5 Stapled Security No Announcement Details Announcement Title Gen
Slide 2: Sponsor contact and attachments
General Announcement::Results Briefing FY2019 Page 2 of 2 The contact persons for the Sponsor are Ms Heng Mui Mui, Managing Director, and Mr Kelvin Wong, Senior Vice President, who can be contacted at 12 Marina Boulevard, Level 46, Marina Bay Financial Centre Tower 3, Singapore 018982, Telephone: +6
Slide 3: Results Briefing FY2019 Disclaimer
3/3/2020 Hyphens Pharma International Limited Results Briefing FY2019 HYPHENS PHARMA INTL LTD (SGX: 1J5) DISCLAIMER This presentation has been prepared by Hyphens Pharma International Limited (the "Company" and, together with its subsidiaries, the "Group"). This content in this presentation is being
Slide 4: Key Developments in FY2019
3/3/2020 KEY DEVELOPMENTS in FY2019 RECAP FY2019 1. Official opening of integrated facilities • Signing of MOU with A*STAR 2
Slide 5: Recap FY2019: Talent and Expanded Product Offerings
3/3/2020 RECAP FY2019 2. Strengthened human talent New Independent Director New Management Team RECAP FY2019 3. Expanded & enhanced product offerings Ceradan in New retail products pharmacies Ocean New Health principals facelift 3
Slide 6: Recap FY2019: Analyst Coverage and Investor Outreach
3/3/2020 RECAP FY2019 4. Analyst initiated coverage @ Target price: S$0.25 – S$0.285 RECAP FY2019 5. Investor outreach 4 8 3 Results Research Research Briefing firms Coverage 4 2 3 Corporate Retail Remisers outreach outreach Luncheon 5 >20 1 5 Investor Fund Online Publications meetings managers Chal
Slide 7: Share Performance and Business Outlook
3/3/2020 SHARE PERFORMANCE 0.27 Trending (2 Jan 2019 - 28 Feb 2020) 320 1J5 FSTICA 310 0.25 300 0.23 +15.38% 290 0.21 280 270 0.19 260 0.17 250 0.15 240 4,000,000 10, Volume 3,000,000 2,000,000 1,000,000 - 2/01/19 2/02/19 2/03/19 2/04/19 2/05/19 2/06/19 2/07/19 2/08/19 2/09/19 2/10/19 2/11/19 2/12/1
Slide 8: Investing for Growth
3/3/2020 INVESTING FOR GROWTH 1• Establishing a broader geographical footprint - Cementing leadership position in Singapore and deepening presence in ASEAN - Expanding international footprint in Asia, Middle East and Africa 2• Investment in proprietary brands - Driving growth of skin health portfoli
Slide 9: Financial Highlights: Revenue & Profits Growth
3/3/2020 FINANCIAL HIGHLIGHTS 1 REVENUE & PROFITS GROWTH Revenue (S$’m) Profit After Tax (S$’m) 6.5 6.1 112.7 120.9 119.4 101 5.4 78.3 5.2 5.1 FY2015 FY2016 FY2017 FY2018 FY2019 FY2015 FY2016 FY2017 FY2018* FY2019 * Incl IPO exp S$0.9m 7
Slide 10: Quarterly Revenue Rising and Segment Revenue
3/3/2020 1.1 QUARTERLY REVENUE RISING S$’000 35,000 32,737 30,886 29,967 30,699 30,000 29,448 29,002 27,004 10,134 9,300 10,210 25,000 9,287 10,187 9,730 9,742 20,000 3,821 3,386 3,089 3,589 3,315 3,638 15,000 3,426 10,000 18,782 18,200 17,591 16,900 15,946 15,634 13,836 5,000 0 2Q2018 3Q2018 4Q2018
Slide 11: Improving Margins; Strong Financial Position & Cash Flow
3/3/2020 2 IMPROVING MARGINS 36.0% 35.0% 34.0% 33.0% 32.0% 31.0% 30.0% FY2015 FY2016 FY2017 FY2018 FY2019 GP margin 32.2% 34.8% 32.8% 33.7% 35.7% 9.0% 8.0% 7.0% 6.0% 5.0% 4.0% FY2015 FY2016 FY2017 FY2018 FY2019 Recurring EBITDA margin 8.1% 6.5% 7.2% 7.4% 8.5% PBT margin 7.7% 5.4% 6.4% 5.8% 6.7% PAT
Slide 12: Higher Dividends and Management Ownership
3/3/2020 4 HIGHER DIVIDENDS S$’000 Dividend Yield(a) Div / NP(b) FY2019 1 cent 4.4% 46.0% FY2018 0.55 cents 2.4% 30.5% (a) Yield is computed based on total dividends declared for the financial year divided by closing price of S$0.255 @ 28 Feb 2020. (b) At least 30% of Net Profits Attributable to Sha
Slide 13: Hyphens Pharma International Limited contact details
3/3/2020 Hyphens Pharma International Limited (SGX: 1J5) 16 Tai Seng Street, Level 4, Singapore 534138 www.hyphensgroup.com 11